Literature DB >> 23676585

An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.

Takaki Matsumoto1, Shiro Uemura, Yukiji Takeda, Masaru Matsui, Sadanori Okada, Taku Nishida, Tsunenari Soeda, Satoshi Okayama, Satoshi Somekawa, Ken-Ichi Ishigami, Kenji Onoue, Hiroyuki Kawata, Rika Kawakami, Manabu Horii, Yoshihiko Saito.   

Abstract

OBJECTIVE: To investigate the predictive values of placental growth factor (PlGF) and its endogenous antagonist, soluble fms-like tyrosine kinase-1 (sFlt-1), for the long-term prognosis of patients with stable coronary artery disease (CAD). Both PlGF and sFlt-1 play important roles in the pathological mechanisms of atherosclerosis. We recently demonstrated that the plasma levels of these molecules are correlated with the severity of coronary atherosclerosis.
METHODS: We enrolled 464 patients with stable CAD who consecutively underwent coronary angiography. Baseline blood samples were collected from the femoral artery immediately before coronary angiography (after the administration of 20 units of heparin), and the plasma levels of PlGF and sFlt-1 were measured. A Cox proportional hazard regression analysis was performed to evaluate the relationship between these parameters and the occurrence of all-cause death (ACD) and total cardiovascular events (TCVE) during a median follow-up of 3.3 years.
RESULTS: A total of 31 ACDs and 51 TCVEs occurred. Patients with higher PlGF/sFlt-1 ratios (>4.22×10(-2)) had a significantly higher risk of both ACD and TCVE than patients with lower ratios (<4.22×10(-2)) (hazard ratio [HR]: 3.32, 95% confidence interval [CI]: 1.43 to 7.72, p=0.005, and HR: 2.23, 95% CI: 1.23 to 4.03, p=0.008, respectively). A multivariate analysis showed the PlGF/sFlt-1 ratio to be an independent predictor for ACD, but not TCVE.
CONCLUSION: The baseline PlGF/sFlt-1 ratio is an independent predictor of long-term adverse outcomes in patients with stable CAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676585     DOI: 10.2169/internalmedicine.52.9073

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.

Authors:  Masaru Matsui; Ken-Ichi Samejima; Yukiji Takeda; Katsuhiko Morimoto; Miho Tagawa; Kenji Onoue; Satoshi Okayama; Hiroyuki Kawata; Rika Kawakami; Yasuhiro Akai; Hiroyuki Okura; Yoshihiko Saito
Journal:  Cardiorenal Med       Date:  2016-03-31       Impact factor: 2.041

2.  Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.

Authors:  Mehdi Rambod; Gunnar H Heine; Sarah Seiler; Elizabeth A Dominic; Kyrill S Rogacev; Rama Dwivedi; Ali Ramezani; Maria R Wing; Richard L Amdur; Danilo Fliser; Dominic S Raj
Journal:  Atherosclerosis       Date:  2014-08-12       Impact factor: 5.162

3.  Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.

Authors:  Masaru Matsui; Shiro Uemura; Yukiji Takeda; Ken-Ichi Samejima; Takaki Matsumoto; Ayako Hasegawa; Hideo Tsushima; Ei Hoshino; Tomoya Ueda; Katsuhiko Morimoto; Keisuke Okamoto; Sadanori Okada; Kenji Onoue; Satoshi Okayama; Hiroyuki Kawata; Rika Kawakami; Naoki Maruyama; Yasuhiro Akai; Masayuki Iwano; Hideo Shiiki; Yoshihiko Saito
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

4.  Ratio between fms-like tyrosine kinase 1 and placental growth factor in children with congenital heart disease.

Authors:  Masaya Sugimoto; Hideharu Oka; Aya Kajihama; Kouichi Nakau; Seiko Kuwata; Clara Kurishima; Hiroshi Azuma
Journal:  Pediatr Cardiol       Date:  2014-11-12       Impact factor: 1.655

5.  Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.

Authors:  Laura Benschop; Sarah Schalekamp-Timmermans; Zoe A Broere-Brown; Jeanine E Roeters van Lennep; Vincent W V Jaddoe; Jolien W Roos-Hesselink; M Kamran Ikram; Eric A P Steegers; James M Roberts; Robin E Gandley
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

Review 6.  Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.

Authors:  Michela Chianca; Giorgia Panichella; Iacopo Fabiani; Alberto Giannoni; Serena L'Abbate; Alberto Aimo; Annamaria Del Franco; Giuseppe Vergaro; Chrysanthos Grigoratos; Vincenzo Castiglione; Carlo Maria Cipolla; Antonella Fedele; Claudio Passino; Michele Emdin; Daniela Maria Cardinale
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 7.  Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Vivek Narayan; Elizabeth W Thompson; Biniyam Demissei; Jennifer E Ho; James L Januzzi; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2020-06-02       Impact factor: 24.094

8.  Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.

Authors:  Edward C A Marks; Tom M Wilkinson; Chris M Frampton; Lorraine Skelton; Anna P Pilbrow; Tim G Yandle; Chris J Pemberton; Robert N Doughty; Gillian A Whalley; Chris J Ellis; Richard W Troughton; Maurice C Owen; Neil R Pattinson; Vicky A Cameron; A Mark Richards; Steven P Gieseg; Barry R Palmer
Journal:  BMC Cardiovasc Disord       Date:  2018-08-15       Impact factor: 2.298

9.  Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol.

Authors:  Johana Ullmo; Monica Cruz-Lemini; Olga Sánchez-García; Lidia Bos-Real; Patricia Fernandez De La Llama; Francesca Calero; Carla Domínguez-Gallardo; Carmen Garrido-Gimenez; Cristina Trilla; Francesc Carreras-Costa; Alessandro Sionis; Josefina Mora; Álvaro García-Osuna; Jordi Ordoñez-Llanos; Elisa Llurba
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-08       Impact factor: 3.007

10.  Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa.

Authors:  Muhammed Ogunlola; Poovendhree Reddy; Maureen N Sibiya; Laura O'Connor; Dorinda Borg; Firoza Haffejee; Shanaz Ghuman; Thembelihle Ngxongo; Nalini Govender
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.